Top 5 Genomics Companies in the World

4. Natera, Inc. (NASDAQ:NTRA)

Latest Market Capitalization: $5.31 billion

Natera, Inc. (NASDAQ:NTRA) sells cancer screening tests, kidney gene panel tests, and other products. The firm’s second quarter earnings provided a strong set of results that saw it grow revenue by 32% annually and increase volumes by 23% indicating strong demand for its products.

After digging through 910 hedge funds for their June quarter of 2023 investments, Insider Monkey discovered that 45 were the firm’s shareholders. Natera, Inc. (NASDAQ:NTRA)’s largest hedge fund investor is Robert Pohly’s Samlyn Capital since it owns 3.5 million shares that are worth $170 million.

Follow Natera Inc. (NASDAQ:NTRA)